Abram Scientific, Inc. news
Abram Scientific today announced it has secured a $2.9 million US Army Grant in support of the company’s effort to address the COVID-19 pandemic. This grant supports the clinical development of the CoagCare System to screen for COVID-19 related blood clotting disorders or coagulopathies in patients. The CoagCare System is intended to aid in the evaluation of clotting disorders and help define appropriate treatment to improve immediate and long-
Abram Scientific today announced it has secured a $2.9 million US Army Grant in support of the company’s effort to address the COVID-19 pandemic. This grant supports the clinical development of the CoagCare System to screen for COVID-19 related blood clotting disorders or coagulopathies in patients. The CoagCare System is intended to aid in the evaluation of clotting disorders and help define appropriate treatment to improve immediate and long-
